Posttransplant Lymphoproliferative Disease after Lung Transplantation

Posttransplant lymphoproliferative disease (PTLD) after lung transplantation occurs due to immunosuppressant therapy which limits antiviral host immunity and permits Epstein-Barr viral (EBV) replication and transformation of B cells. Mechanistically, EBV survives due to latency, escape from cytotoxi...

詳細記述

書誌詳細
出版年:Clinical and Developmental Immunology
第一著者: Isabel P. Neuringer
フォーマット: 論文
言語:英語
出版事項: Wiley 2013-01-01
オンライン・アクセス:http://dx.doi.org/10.1155/2013/430209

類似資料